Is this Reece's Icarus moment?
The plumbing supplies business is taking advantage of its excellent reputation to make a significant acquisition in the 'Sun Belt' of the United States.
Macquarie Group: Result 2018
The investment bank has beaten its guidance again, but the composition of its profit was less impressive.
Sirtex Medical gets a better offer
Sirtex Medical has received a second juicy takeover offer from a Chinese fund manager.
Ainsworth disappoints ... again
This pokie maker shows no sign of a turnaround, so it's time to let go.
Platinum shares bounce
The fund manager's share price has recovered a little after the recent sell-off.
JB Hi-Fi joins the club
The profit downgrade club isn't one companies want to join - but JB Hi-Fi has finally succumbed following the 2016 acquisition of The Good Guys.
Nanosonics and that one pesky customer
This sterilisation device maker has a new product, but customer troubles could lead to short-term trouble.
InvoCare starts to stumble
It wasn't hard to work out InvoCare was in for a rough 2018. Unfortunately it's likely to get worse.
Village Roadshow under review
We're updating our view on Village Roadshow and have removed the price guide for the time being.
Servcorp warns again
This serviced office provider is getting into a nasty habit with profit warnings, and there could be more to come.
Wesfarmers sales surprise
With customer satisfaction at Coles improving and Bunnings UK & Ireland less bad than it looked, the release of the latest sales results delivered some positive news.
IOOF gets the royal treatment
The Royal Commission has increased some of the risks for IOOF, but there are reasons for confidence.
Growth Portfolio buys
There's not much business growth in our Equity Growth Portfolio's latest purchase, but there appears to be plenty of value.
ResMed's one-off tax troubles
ResMed has announced another quarter of good profit growth despite a shrinking gross margin.
AustralianSuper flirts with Healthscope
Australia's second largest private hospital network has received a proposal from a group of asset managers.
Three lessons from Alumina
We rightly look for lessons from our mistakes but we can also learn a thing or three from our winners too.
Navitas price guide lowered
Weaker enrolment growth prospects have forced a reassessment of potential profit upside over the next 18 months. We're reducing our price guide.
Is iSelect a value trap?
iSelect is losing customers in droves. Here we outline the bull and bear cases.
iSelect slashes guidance
iSelect continues to experience poor results and its chief executive has paid the price.
Call 1300 880 160
Start a chat
Schedule a call
